These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 35395866

  • 1. Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome.
    Kolevzon A, Breen MS, Siper PM, Halpern D, Frank Y, Rieger H, Weismann J, Trelles MP, Lerman B, Rapaport R, Buxbaum JD.
    Mol Autism; 2022 Apr 08; 13(1):17. PubMed ID: 35395866
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.
    Fastman J, Foss-Feig J, Frank Y, Halpern D, Harony-Nicolas H, Layton C, Sandin S, Siper P, Tang L, Trelles P, Zweifach J, Buxbaum JD, Kolevzon A.
    Mol Autism; 2021 Sep 30; 12(1):62. PubMed ID: 34593045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.
    Dyar B, Meaddough E, Sarasua SM, Rogers C, Phelan K, Boccuto L.
    Genes (Basel); 2021 Jul 30; 12(8):. PubMed ID: 34440366
    [Abstract] [Full Text] [Related]

  • 6. Sensory Reactivity Phenotype in Phelan-McDermid Syndrome Is Distinct from Idiopathic ASD.
    Tavassoli T, Layton C, Levy T, Rowe M, George-Jones J, Zweifach J, Lurie S, Buxbaum JD, Kolevzon A, Siper PM.
    Genes (Basel); 2021 Jun 26; 12(7):. PubMed ID: 34206779
    [Abstract] [Full Text] [Related]

  • 7. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
    Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE.
    Orphanet J Rare Dis; 2015 Aug 27; 10():105. PubMed ID: 26306707
    [Abstract] [Full Text] [Related]

  • 8. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.
    Richards C, Powis L, Moss J, Stinton C, Nelson L, Oliver C.
    J Neurodev Disord; 2017 Nov 10; 9(1):37. PubMed ID: 29126394
    [Abstract] [Full Text] [Related]

  • 9. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
    Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, Pessoa ALS, Perez ABA, Lourenço N, Vibranovski M, Krepischi A, Rosenberg C, Passos-Bueno MR.
    J Neurodev Disord; 2019 Jul 18; 11(1):13. PubMed ID: 31319798
    [Abstract] [Full Text] [Related]

  • 10. Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial.
    Zwanenburg RJ, Bocca G, Ruiter SA, Dillingh JH, Flapper BC, van den Heuvel ER, van Ravenswaaij-Arts CM.
    Eur J Hum Genet; 2016 Dec 18; 24(12):1696-1701. PubMed ID: 27577546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gait Abnormalities in Children with Phelan-McDermid Syndrome.
    Frank Y, Levy T, Lozano R, Friedman K, Underwood S, Kostic A, Walker H, Kolevzon A.
    J Child Neurol; 2023 Dec 18; 38(13-14):665-671. PubMed ID: 37849292
    [Abstract] [Full Text] [Related]

  • 13. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome.
    Mieses AM, Tavassoli T, Li E, Soorya L, Lurie S, Wang AT, Siper PM, Kolevzon A.
    J Autism Dev Disord; 2016 Jul 18; 46(7):2508-13. PubMed ID: 26914612
    [Abstract] [Full Text] [Related]

  • 14. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.
    Cammarata-Scalisi F, Callea M, Martinelli D, Willoughby CE, Tadich AC, Araya Castillo M, Lacruz-Rengel MA, Medina M, Grimaldi P, Bertini E, Nevado J.
    Genes (Basel); 2022 Mar 12; 13(3):. PubMed ID: 35328058
    [Abstract] [Full Text] [Related]

  • 15. Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models.
    Kozol RA, Dallman JE.
    F1000Res; 2023 Mar 12; 12():84. PubMed ID: 37868296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Neurological Manifestations of Phelan-McDermid Syndrome.
    Frank Y.
    Pediatr Neurol; 2021 Sep 12; 122():59-64. PubMed ID: 34325981
    [Abstract] [Full Text] [Related]

  • 18. Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome.
    Gergoudis K, Weinberg A, Templin J, Farmer C, Durkin A, Weissman J, Siper P, Foss-Feig J, Del Pilar Trelles M, Bernstein JA, Buxbaum JD, Berry-Kravis E, Powell CM, Sahin M, Soorya L, Thurm A, Kolevzon A, Developmental Synaptopathies ConsortiumDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA..
    Autism Res; 2020 Aug 12; 13(8):1383-1396. PubMed ID: 32406614
    [Abstract] [Full Text] [Related]

  • 19. Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the Shank3 Gene.
    Drapeau E, Riad M, Kajiwara Y, Buxbaum JD.
    eNeuro; 2018 Aug 12; 5(3):. PubMed ID: 30302388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.